Zevra Therapeutics (ZVRA) Non Operating Interest Expenses (2014 - 2026)
Zevra Therapeutics (ZVRA) posted Non Operating Interest Expenses of $1.71 million for Q1 2026, down 13.1% from $1.97 million a year earlier and down 12.2% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Non Operating Interest Expenses (2014 - 2026) Analysis & Trends
For FY2025, Zevra Therapeutics' Non Operating Interest Expenses came in at $7.98 million, up 8.5% from FY2024.
- Annual Non Operating Interest Expenses has increased for four consecutive years, with a five-year compound annual growth rate of 10.8% (FY2020 to FY2025).
- In prior years, Zevra Therapeutics' Non Operating Interest Expenses was $7.35 million in FY2024 (+389.7%), $1.5 million in FY2023 (+348.1%), $335,000 in FY2022 (+48.2%) and $226,000 in FY2021 (-95.3%).
- The Q1 2026 figure stands as the lowest quarterly Non Operating Interest Expenses since Q1 2024.
- On a year-over-year basis, Non Operating Interest Expenses has declined in each of the last four quarters, with growth averaging 227.6% over the last eight quarters.
- The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was Q2 2024, with growth of 971.1%; the weakest was Q4 2021, with a decline of 99.6%.
- According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $1.95 million (Q4 2025), $2.05 million (Q3 2025) and $2.01 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 281.00 Mn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -462.00 Mn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -435.00 Mn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 673.00 Mn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 247.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Zevra Therapeutics | 604.10 Mn | -208.61 Mn | 38.18 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.71 Mn |
| Dec 31, 2025 | 1.95 Mn |
| Sep 30, 2025 | 2.05 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Mar 31, 2025 | 1.97 Mn |
| Dec 31, 2024 | 2.19 Mn |
| Sep 30, 2024 | 2.31 Mn |
| Jun 30, 2024 | 2.11 Mn |
| Mar 31, 2024 | 735,000.00 |
| Dec 31, 2023 | 756,000.00 |
| Sep 30, 2023 | 366,000.00 |
| Jun 30, 2023 | 197,000.00 |
| Mar 31, 2023 | 182,000.00 |
| Dec 31, 2022 | 170,000.00 |
| Sep 30, 2022 | 124,000.00 |
| Jun 30, 2022 | 36,000.00 |
| Mar 31, 2022 | 5,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 6,000.00 |
| Jun 30, 2021 | 16,000.00 |
API Access
Zevra Therapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();